Letter: Aquagenic keratoderma: successful treatment with botulinum toxin.
Bagazgoitia
Lorea
L
Pérez-Carmona
Lucía
L
Salgüero
Irene
I
Harto
Antonio
A
Jaén
Pedro
P
D000328:Adult; D000077410:Aluminum Chloride; D017607:Aluminum Compounds / Q000627:therapeutic use; D001252:Astringents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002712:Chlorides / Q000627:therapeutic use; D005260:Female; D006225:Hand; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000628:therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D017211:Treatment Failure
D017607:Aluminum Compounds; D001252:Astringents; D002712:Chlorides; D009465:Neuromuscular Agents; D000077410:Aluminum Chloride; D019274:Botulinum Toxins, Type A